title: ITPA genotyping is not predictive for the development of side effects in AZA treated inflammatory bowel disease patients.
authors.forename: J M
authors.initials: JM
authors.lastname: van Dieren
authors.forename: A J
authors.initials: AJ
authors.lastname: van Vuuren
authors.forename: J G
authors.initials: JG
authors.lastname: Kusters
authors.forename: E E S
authors.initials: EE
authors.lastname: Nieuwenhuis
authors.forename: E J
authors.initials: EJ
authors.lastname: Kuipers
authors.forename: C J
authors.initials: CJ
authors.lastname: van der Woude
mesh_terms: D001379:Azathioprine / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D008780:Methyltransferases / Q000235:genetics; D011110:Polymorphism, Genetic; D011755:Pyrophosphatases / Q000235:genetics*; D000097630:Inosine Triphosphatase
chemical_list: D001379:Azathioprine; D007166:Immunosuppressive Agents; D008780:Methyltransferases; D011755:Pyrophosphatases; D000097630:Inosine Triphosphatase; C022745:thiopurine methyltransferase